The United States Lactulose Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Lactulose Market By Application
- Constipation
- Hepatic Encephalopathy
- Others (including Pediatric Use)
The United States lactulose market is segmented by application into several key . Constipation remains the largest application segment, driven by the rising prevalence of gastrointestinal disorders and increasing consumer preference for non-prescription laxatives. Lactulose’s effectiveness in treating chronic constipation by drawing water into the bowel and softening stools has sustained its demand in this segment.
Hepatic encephalopathy represents another significant application area for lactulose. This segment is characterized by the use of lactulose to reduce blood ammonia levels in patients with liver cirrhosis, thereby managing and preventing episodes of hepatic encephalopathy. Moreover, lactulose finds niche applications in other areas, including its use in pediatric populations for conditions such as encopresis and functional constipation, although to a lesser extent compared to adult applications.